Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia

During the coronavirus disease 2019 (COVID-19) pandemic, patients with humoral immunodeficiency are at higher risk of developing chronic infection and having a negative outcome. Few data are available on therapeutic options for this population. This case report discusses the treatment of disease rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Palomba, Emanuele, Carrabba, Maria, Zuglian, Gianluca, Alagna, Laura, Saltini, Paola, Fortina, Valeria, Hu, Cinzia, Bandera, Alessandra, Fabio, Giovanna, Gori, Andrea, Muscatello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317455/
https://www.ncbi.nlm.nih.gov/pubmed/34332085
http://dx.doi.org/10.1016/j.ijid.2021.07.064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317455/
https://www.ncbi.nlm.nih.gov/pubmed/34332085
http://dx.doi.org/10.1016/j.ijid.2021.07.064

Ejemplares similares